Alcon Inc. Ordinary Shares (ALC) Financial Statements
Historical financial data — 5 statements covering FY2021–FY2025
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visi...
Alcon Inc. Ordinary Shares's revenue increased 4.9% year over year, from $9.91B to $10.40B.
Net income decreased 3.7% over the same period, from $1.02B to $980.0M.
Over the 4-year period from FY2021 to FY2025, revenue grew by 25% in total.
Total debt remained relatively stable at $5.25B.
The debt-to-equity ratio stands at 0.24, indicating a conservative leverage profile.
Alcon Inc. Ordinary Shares maintains a moderate net profit margin of 9.4%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2021 | $8.29B | $376.0M | $4.65B | $580.0M | N/A | $28.00B | $4.49B | $19.26B |
| FY2022 | $8.72B+5.1% | $335.0M | $4.75B | $672.0M | N/A | $29.16B | $5.08B | $19.68B |
| FY2023 | $9.46B+8.5% | $974.0M | $5.25B | $1.04B | N/A | $29.61B | $5.14B | $20.62B |
| FY2024 | $9.91B+4.8% | $1.02B | $5.51B | $1.41B | N/A | $30.35B | $5.14B | $21.55B |
| FY2025 | $10.40B+4.9% | $980.0M | $5.75B | $1.36B | N/A | $31.55B | $5.25B | $22.04B |
Balance Sheet Summary (Latest Period)
Total Assets
$31.55B
Total Liabilities
$9.52B
Total Equity
$22.04B
Cash & Equivalents
$1.61B
Total Debt
$5.25B
Current Assets
$6.45B
Current Liabilities
$3.05B
Retained Earnings
$22.01B